Wired Herald

Joint Pain Injections Market to Reach $ 5.7 Billion, Globally By 2026

Press release   •   Jul 16, 2019 07:44 EDT

The global Joint Pain Injections Market Size is expected to reach 5.7 billion by 2026. The market is estimated to grow at a CAGR of 8.0% during the forecast period from 2019 to 2026.

Acumen Research and Consulting has recently published a research report on the Joint Pain Injections Market for the forecast period of 2019 to 2026, wherein, the global market has been analyzed and assessed in an extremely comprehensive manner. The research report on the Joint Pain Injections Market offers an extensive analysis of how the postoperative pain therapeutics landscape would evolve through 2026.

The research study on the Joint Pain Injections Market analyzes key drivers upholding product sales and prominent trends shaping the growth of the market. The research study not only focuses on the latent opportunities for the key stakeholders of the market, but also sheds light on the notable developments and future scope for innovation in the landscape.

Free Download Sample Report Pages for Better Understanding@ https://www.acumenresearchandconsulting.com/request-sample/1352

The report starts off with a quick executive summary, wherein, key takeaways have been highlighted for the readers to have a sneak peak at the key market segments. The research study by ARC on the market also talks about the macroeconomic and microeconomic factors having deep-rooted influences on global market growth. The research study on the Joint Pain Injections Market also offers a regional analysis, wherein, demand across every region has been comprehensively analyzed.

The report also analyzes the Joint Pain Injections Market on the basis of various segments, with drug type being a prominent one. A unique section in the report also offers a detailed breakdown on the basis of route of administration – which one is highly preferred and which one is minimally preferred.

Market Segmentation

Market, by Type

  • Hyaluronic Acid Injections
  • Corticosteroid Injections

Market, by Joint Type

  • Knee and Ankle
  • Shoulder and Elbow
  • Hip Joint
  • Facet Joints of the Spine

Market, by Distribution Channel

  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies

Market, by Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Chile
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA

The market research study on “Joint Pain Injections Market - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026” offers detailed insights on global Joint Pain Injections market segments with market dynamics and their impact. The report also covers basic technology development policies.

Key Questions Answered in the Report

The report addresses key questions concerning the market evolution and overarching trends shaping global market growth. Some of the key questions answered in the report include-

What is the overall structure of the market?

What was the historical value and what is the forecasted value of the market?

What are the key product level trends in the market?

What are the market level trends in the market?

Which of the market players are leading and what are their key differential strategies to retain their stronghold?

Which are the most lucrative regions in the market space?

Buy this Premium Research Report@ https://www.acumenresearchandconsulting.com/buy-now/0/1352

Research Methodology

The report on the Joint Pain Injections Market is based on an extensive and meticulous bottom up approach, which was used to determine the market size.

In the primary phase of the research methodology focus on, key stakeholders, including CEOs, presidents, vice presidents, chief medical officers, and product/sales/marketing managers were interviewed for the purpose of garnering unique insights into the dynamics of the market.

Market Participants:

Allergan Plc., Pfizer Inc., Sanofi, Ferring B.V., Flexion Therapeutics, Inc.., Anika Therapeutics, Inc., SEIKAGAKU CORPORATION, and Chugai Pharmaceutical Co., Ltd. are major actors operating on the common pain injections market. Inc. Key players expand their product portfolio by combining, acquiring and cooperating with leading medical firms that are expected to improve the availability of the products and thus boost the market.

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
1.1.1. Definition of Joint Pain Injections
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Joint Pain Injections Market By Type
1.2.2.1. Global Joint Pain Injections Market Revenue and Growth Rate Comparison By Type (2015-2026)
1.2.2.2. Global Joint Pain Injections Market Revenue Share By Type in 2017
1.2.2.3. Hyaluronic Acid Injections
1.2.2.4. Corticosteroid Injections
1.2.3. Joint Pain Injections Market By Joint Type
1.2.3.1. Global Joint Pain Injections Market Revenue and Growth Rate Comparison By Joint Type (2015-2026)
1.2.3.2. Global Joint Pain Injections Market Revenue Share By Joint Type in 2017
1.2.3.3. Knee and Ankle
1.2.3.4. Shoulder and Elbow
1.2.3.5. Hip Joint
1.2.3.6. Facet Joints of the Spine
1.2.4. Joint Pain Injections Market By Distribution Channel
1.2.4.1. Global Joint Pain Injections Market Revenue and Growth Rate Comparison By Distribution Channel (2015-2026)
1.2.4.2. Global Joint Pain Injections Market Revenue Share By Distribution Channel in 2017
1.2.4.3. Hospital Pharmacies
1.2.4.4. Online Pharmacies
1.2.4.5. Retail Pharmacies
1.2.5. Joint Pain Injections Market by Geography
1.2.5.1. Global Joint Pain Injections Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.5.2. North America Joint Pain Injections Market Revenue and Growth Rate (2015-2026)
1.2.5.3. Europe Joint Pain Injections Market Revenue and Growth Rate (2015-2026)
1.2.5.4. Asia-Pacific Joint Pain Injections Market Revenue and Growth Rate (2015-2026)
1.2.5.5. Latin America Joint Pain Injections Market Revenue and Growth Rate (2015-2026)
1.2.5.6. Middle East and Africa (MEA) Joint Pain Injections Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Joint Pain Injections Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Joint Pain Injections Major Manufacturers in 2017
3.3. R&D Status and Technology Source of Global Joint Pain Injections Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Joint Pain Injections Major Manufacturers in 2017

CHAPTER 4. JOINT PAIN INJECTIONS MARKET BY TYPE

4.1. Global Joint Pain Injections Revenue By Type
4.2. Hyaluronic Acid Injections
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Corticosteroid Injections
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. JOINT PAIN INJECTIONS MARKET BY JOINT TYPE

5.1. Global Joint Pain Injections Revenue By Joint Type
5.2. Knee and Ankle
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Shoulder and Elbow
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Hip Joint
5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.5. Facet Joints of the Spine
5.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. JOINT PAIN INJECTIONS MARKET BY DISTRIBUTION CHANNEL

6.1. Global Joint Pain Injections Revenue By Distribution Channel
6.2. Hospital Pharmacies
6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3. Online Pharmacies
6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.4. Retail Pharmacies
6.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 7. NORTH AMERICA JOINT PAIN INJECTIONS MARKET BY COUNTRY

7.1. North America Joint Pain Injections Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. North America Joint Pain Injections Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. U.S.
7.3.1. U.S. Joint Pain Injections Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By Joint Type, 2015 - 2026 ($Million)
7.4. Canada
7.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By Joint Type, 2015 - 2026 ($Million)
7.5. Mexico
7.5.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast By Joint Type, 2015 - 2026 ($Million)

CHAPTER 8. EUROPE JOINT PAIN INJECTIONS MARKET BY COUNTRY

8.1. Europe Joint Pain Injections Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Europe Joint Pain Injections Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. UK
8.3.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Joint Type, 2015 - 2026 ($Million)
8.4. Germany
8.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Joint Type, 2015 - 2026 ($Million)
8.5. France
8.5.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By Joint Type, 2015 - 2026 ($Million)
8.6. Spain
8.6.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
8.6.2. Market Revenue and Forecast By Joint Type, 2015 - 2026 ($Million)
8.7. Rest of Europe
8.7.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
8.7.2. Market Revenue and Forecast By Joint Type, 2015 - 2026 ($Million)

CHAPTER 9. ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET BY COUNTRY

9.1. Asia-Pacific Joint Pain Injections Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Asia-Pacific Joint Pain Injections Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. China
9.3.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Joint Type, 2015 - 2026 ($Million)
9.4. Japan
9.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Joint Type, 2015 - 2026 ($Million)
9.5. India
9.5.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Joint Type, 2015 - 2026 ($Million)
9.6. Australia
9.6.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.6.2. Market Revenue and Forecast By Joint Type, 2015 - 2026 ($Million)
9.7. South Korea
9.7.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.7.2. Market Revenue and Forecast By Joint Type, 2015 - 2026 ($Million)
9.8. Rest of Asia-Pacific
9.8.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.8.2. Market Revenue and Forecast By Joint Type, 2015 - 2026 ($Million)

CHAPTER 10. LATIN AMERICA JOINT PAIN INJECTIONS MARKET BY COUNTRY

10.1. Latin America Joint Pain Injections Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Latin America Joint Pain Injections Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Brazil
10.3.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Joint Type, 2015 - 2026 ($Million)
10.4. Argentina
10.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Joint Type, 2015 - 2026 ($Million)
10.5. Rest of Latin America
10.5.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Joint Type, 2015 - 2026 ($Million)

CHAPTER 11. MIDDLE EAST JOINT PAIN INJECTIONS MARKET BY COUNTRY

11.1. Middle East Joint Pain Injections Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Middle East Joint Pain Injections Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. Saudi Arabia
11.3.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By Joint Type, 2015 - 2026 ($Million)
11.4. UAE
11.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By Joint Type, 2015 - 2026 ($Million)
11.5. Rest of Middle East
11.5.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By Joint Type, 2015 - 2026 ($Million)

CHAPTER 12. AFRICA JOINT PAIN INJECTIONS MARKET BY COUNTRY

12.1. Africa Joint Pain Injections Market Revenue and Growth Rate, 2015 - 2026 ($Million)
12.2. Africa Joint Pain Injections Market Revenue Share Comparison, 2015 & 2026 (%)
12.3. South Africa
12.3.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
12.3.2. Market Revenue and Forecast By Joint Type, 2015 - 2026 ($Million)
12.4. Egypt
12.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
12.4.2. Market Revenue and Forecast By Joint Type, 2015 - 2026 ($Million)
12.5. Rest of Africa
12.5.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
12.5.2. Market Revenue and Forecast By Joint Type, 2015 - 2026 ($Million)

CHAPTER 13. COMPANY PROFILE

13.1. Allergan Plc.
13.1.1. Company Snapshot
13.1.2. Overview
13.1.3. Financial Overview
13.1.4. Product Portfolio
13.1.5. Key Developments
13.1.6. Strategies
13.2. Pfizer Inc.
13.2.1. Company Snapshot
13.2.2. Overview
13.2.3. Financial Overview
13.2.4. Product Portfolio
13.2.5. Key Developments
13.2.6. Strategies
13.3. Sanofi
13.3.1. Company Snapshot
13.3.2. Overview
13.3.3. Financial Overview
13.3.4. Product Portfolio
13.3.5. Key Developments
13.3.6. Strategies
13.4. Ferring B.V.
13.4.1. Company Snapshot
13.4.2. Overview
13.4.3. Financial Overview
13.4.4. Product Portfolio
13.4.5. Key Developments
13.4.6. Strategies
13.5. Flexion Therapeutics, Inc.
13.5.1. Company Snapshot
13.5.2. Overview
13.5.3. Financial Overview
13.5.4. Product Portfolio
13.5.5. Key Developments
13.5.6. Strategies
13.6. Anika Therapeutics, Inc
13.6.1. Company Snapshot
13.6.2. Overview
13.6.3. Financial Overview
13.6.4. Product Portfolio
13.6.5. Key Developments
13.6.6. Strategies
13.7. SEIKAGAKU CORPORATION
13.7.1. Company Snapshot
13.7.2. Overview
13.7.3. Financial Overview
13.7.4. Product Portfolio
13.7.5. Key Developments
13.7.6. Strategies
13.8. Chugai Pharmaceutical Co., Ltd.
13.8.1. Company Snapshot
13.8.2. Overview
13.8.3. Financial Overview
13.8.4. Product Portfolio
13.8.5. Key Developments
13.8.6. Strategies
13.9. Others
13.9.1. Company Snapshot
13.9.2. Overview
13.9.3. Financial Overview
13.9.4. Product Portfolio
13.9.5. Key Developments
13.9.6. Strategies

CHAPTER 14. RESEARCH APPROACH

14.1. Research Methodology
14.1.1. Initial Data Search
14.1.2. Secondary Research
14.1.3. Primary Research
14.2. Assumptions and Scope

To Purchase this Premium Report@ https://www.acumenresearchandconsulting.com/buy-now/0/1352

The report is readily available and can be dispatched immediately after payment confirmation.

Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157

About Acumen Research and Consulting:

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.